BioNTech

The European Medicines Agency said on Dec. 21 that it had approved the Pfizer-BioNTech coronavirus vaccine, paving the way for inoculations to start across the EU within days.    

The Amsterdam-based regulator dramatically moved the decision on the jab ahead from December 29, following pressure to accelerate the process from Germany and other EU states.    

The European Medicines Agency says an expert committee has recommended conditional approval for a coronavirus vaccine developed by BioNTech and Pfizer to be used across the European Union, weeks after the shot was first granted permission under emergency provisions in Britain and the United States.

The first doses of the vaccine made by the Pfizer and BioNtech companies will arrive in Serbia this week, Pavle Zelic, from the Serbia's Agency for Medicines, said on Monday.

Το Ισραήλ έχει παραγγείλει συνολικά 14 εκατομμύρια δόσεις εμβολίων των Pfizer-BioNTech και Moderna

Κύπρος: Παραλαμβάνονται τα ειδικά ψυγεία φύλαξης των εμβολίων των Pfizer-BioNTech

Vaccines developed by Sinovac Biotech Ltd. and the state-owned China National Biotec Group Co. have been dispensed in the country since they were granted emergency-use authorization in July.

The U.S. added a second COVID-19 vaccine to its arsenal on Dec. 18, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.

Much-needed doses are set to arrive Monday after the Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. and the National Institutes of Health.

U.S. Vice President Mike Pence received his COVID-19 vaccine live on television on Friday, seeking to shore up public support for vaccinations after U.S. deaths from the coronavirus topped 3,000 for a third straight day.

On December 2, Pfizer and BioNTech submitted documentation for the registration of the coronavirus vaccine in Serbia, after which Medicines and Medical Devices Agency of Serbia began evaluating the documents and thoroughly studying all phases of testing, in order to confirm the efficacy and safety of the vaccine.

A second coronavirus vaccine is nearing emergency approval in the US after it was endorsed by a panel of experts.

The head of the Food and Drug Administration (FDA) said his agency would move quickly to authorise the Moderna vaccine, allowing the company to begin shipping millions of doses.